NG
NatWest Group Portfolio holdings
AUM
$338M
1-Year Return
41.28%
This Quarter Return
-1.4%
1 Year Return
+41.28%
3 Year Return
+173.76%
5 Year Return
+281.78%
10 Year Return
+568.43%
AUM
$7.61B
AUM Growth
+$7.6B
(+64,485%)
Cap. Flow
-$3.9B
Cap. Flow
% of AUM
-51.31%
Top 10 Holdings %
Top 10 Hldgs %
79.06%
Holding
474
New
33
Increased
103
Reduced
265
Closed
37
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$47.5M |
| 2 |
NVIDIA
NVDA
|
+$8.9M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$8.42M |
| 4 |
Morgan Stanley
MS
|
+$8.23M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$7.3M |
Top Sells
| 1 |
Citizens Financial Group
CFG
|
+$3.75B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$192M |
| 3 |
TBAR
ROYAL BANK OF SCOTLAND PLC RBS GOLD TRENDPILOT ETN (NL)
TBAR
|
+$20.2M |
| 4 |
Wells Fargo
WFC
|
+$18.6M |
| 5 |
SPDR Gold Trust
GLD
|
+$12.2M |
Sector Composition
| 1 | Financials | 75.93% |
| 2 | Technology | 3.3% |
| 3 | Healthcare | 3.3% |
| 4 | Industrials | 2.75% |
| 5 | Communication Services | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
IQVIA
IQV
$31.9B
| $949K | 0.01% |
14,168
+1,002
| +8% | +$67.1K |
|
227
CME Group
CME
$94.6B
| $947K | 0.01% |
10,000
-52
| -0.5% | -$4.92K |
|
228
Celldex Therapeutics
CLDX
$1.55B
| $939K | 0.01% |
+2,246
| New | +$939K |
|
229
Norfolk Southern
NSC
$61.8B
| $936K | 0.01% |
9,095
-647
| -7% | -$66.6K |
|
230
eBay
EBAY
$42.5B
| $914K | 0.01% |
37,631
+7,389
| +24% | +$179K |
|
231
Vertex Pharmaceuticals
VRTX
$101B
| $904K | 0.01% |
7,664
+4,961
| +184% | +$585K |
|
232
Textron
TXT
$14.7B
| $873K | 0.01% |
19,700
-1,980
| -9% | -$87.7K |
|
233
Energy Select Sector SPDR Fund
XLE
$26.7B
| $871K | 0.01% |
11,224
-50
| -0.4% | -$3.88K |
|
234
CEMIG Preferred Shares
CIG
$5.78B
| $860K | 0.01% |
412,706
-158,510
| -28% | -$330K |
|
|
TBAR
235
DELISTED
ROYAL BANK OF SCOTLAND PLC RBS GOLD TRENDPILOT ETN (NL)
TBAR
| $859K | 0.01% |
36,000
-846,825
| -96% | -$20.2M |
|
236
Regeneron Pharmaceuticals
REGN
$59.2B
| $858K | 0.01% |
1,900
+321
| +20% | +$145K |
|
237
BioMarin Pharmaceuticals
BMRN
$10.8B
| $857K | 0.01% |
6,873
-1,402
| -17% | -$175K |
|
|
PX
238
DELISTED
Praxair Inc
PX
| $856K | 0.01% |
7,091
+1,279
| +22% | +$154K |
|
239
Incyte
INCY
$16.9B
| $845K | 0.01% |
9,218
-2,425
| -21% | -$222K |
|
|
AKRX
240
DELISTED
Akorn, Inc.
AKRX
| $841K | 0.01% |
17,697
-4,123
| -19% | -$196K |
|
241
United Therapeutics
UTHR
$17.8B
| $838K | 0.01% |
4,857
+177
| +4% | +$30.5K |
|
242
iShares MSCI Taiwan ETF
EWT
$6.33B
| $833K | 0.01% |
26,433
| – | – |
|
243
iShares Russell 1000 Growth ETF
IWF
$118B
| $832K | 0.01% |
8,413
| – | – |
|
244
Novavax
NVAX
$1.26B
| $831K | 0.01% |
+5,021
| New | +$831K |
|
|
PTR
245
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $824K | 0.01% |
7,409
+2,900
| +64% | +$323K |
|
246
Aflac
AFL
$56.9B
| $821K | 0.01% |
25,668
-508
| -2% | -$16.2K |
|
247
Ford
F
$46.5B
| $819K | 0.01% |
50,793
-10,560
| -17% | -$170K |
|
|
ALXN
248
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $819K | 0.01% |
4,725
+1,057
| +29% | +$183K |
|
249
Target
TGT
$41.6B
| $814K | 0.01% |
9,923
+186
| +2% | +$15.3K |
|
|
MDVN
250
DELISTED
MEDIVATION, INC.
MDVN
| $814K | 0.01% |
12,608
+236
| +2% | +$15.2K |
|